| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assuring the Patient Centeredness of Patient-Reported Outcomes: Content Validity in Medical Product Development and Comparative Effectiveness Research
|
Basch, Ethan
|
|
2011
|
14 |
8 |
p. 965-966
2 p.
|
artikel
|
| 2 |
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing Respondent Understanding
|
Patrick, Donald L.
|
|
2011
|
14 |
8 |
p. 978-988
11 p.
|
artikel
|
| 3 |
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO Instrument
|
Patrick, Donald L.
|
|
2011
|
14 |
8 |
p. 967-977
11 p.
|
artikel
|
| 4 |
Copyright/Subscription
|
|
|
2011
|
14 |
8 |
p. iv-
1 p.
|
artikel
|
| 5 |
Cost-Effectiveness Analysis of a Universal Infant Immunization Program with Meningococcal C Conjugate Vaccine in Brazil
|
de Soarez, Patricia Coelho
|
|
2011
|
14 |
8 |
p. 1019-1027
9 p.
|
artikel
|
| 6 |
Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia
|
Hoyle, Martin
|
|
2011
|
14 |
8 |
p. 1057-1067
11 p.
|
artikel
|
| 7 |
Cost-Effectiveness of Lanthanum Carbonate versus Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease: A US Payer Perspective
|
Park, Haesuk
|
|
2011
|
14 |
8 |
p. 1002-1009
8 p.
|
artikel
|
| 8 |
Cost-Effectiveness of the Introduction of a Pre-Erythrocytic Malaria Vaccine into the Expanded Program on Immunization in Sub-Saharan Africa: Analysis of Uncertainties Using a Stochastic Individual-Based Simulation Model of Plasmodium falciparum Malaria
|
Maire, Nicolas
|
|
2011
|
14 |
8 |
p. 1028-1038
11 p.
|
artikel
|
| 9 |
Cost-Utility Analyses of Diagnostic Laboratory Tests: A Systematic Review
|
Fang, ChiHui
|
|
2011
|
14 |
8 |
p. 1010-1018
9 p.
|
artikel
|
| 10 |
Developing and Applying a Stochastic Dynamic Population Model for Chronic Obstructive Pulmonary Disease
|
Hoogendoorn, Martine
|
|
2011
|
14 |
8 |
p. 1039-1047
9 p.
|
artikel
|
| 11 |
Development, Reliability, and Validity of a New Preference and Satisfaction Questionnaire
|
Gold, Deborah T.
|
|
2011
|
14 |
8 |
p. 1109-1116
8 p.
|
artikel
|
| 12 |
DRG-Based Hospital Payment Systems and Technological Innovation in 12 European Countries
|
Scheller-Kreinsen, David
|
|
2011
|
14 |
8 |
p. 1166-1172
7 p.
|
artikel
|
| 13 |
Economics of Switching to Second-Line Antiretroviral Therapy with Lopinavir/Ritonavir in Africa: Estimates Based on DART Trial Results and Costs for Uganda and Kenya
|
Simpson, Kit N.
|
|
2011
|
14 |
8 |
p. 1048-1054
7 p.
|
artikel
|
| 14 |
Editorial Board
|
|
|
2011
|
14 |
8 |
p. IFC-
1 p.
|
artikel
|
| 15 |
Effect of Health-Related Quality-Of-Life Instrument and Quality-Adjusted Life Year Calculation Method on the Number of Life Years Gained in the Critical Care Setting
|
Vainiola, Tarja
|
|
2011
|
14 |
8 |
p. 1130-1134
5 p.
|
artikel
|
| 16 |
Elicitation of Informed General Population Health State Utility Values: A Review of the Literature
|
McTaggart-Cowan, Helen
|
|
2011
|
14 |
8 |
p. 1153-1157
5 p.
|
artikel
|
| 17 |
EQ-5D for the Assessment of Health-Related Quality of Life and Resource Allocation in Children: A Systematic Methodological Review
|
Noyes, J.
|
|
2011
|
14 |
8 |
p. 1117-1129
13 p.
|
artikel
|
| 18 |
Estimating Population-Based Values for EQ-5D Health States in Thailand
|
Tongsiri, Sirinart
|
|
2011
|
14 |
8 |
p. 1142-1145
4 p.
|
artikel
|
| 19 |
Guide for Authors
|
|
|
2011
|
14 |
8 |
p. IV-V
nvt p.
|
artikel
|
| 20 |
Methods for Using Data Abstracted from Medical Charts to Impute Longitudinal Missing Data in a Clinical Trial
|
Hebert, Paul L.
|
|
2011
|
14 |
8 |
p. 1085-1091
7 p.
|
artikel
|
| 21 |
Practical Implications of Differential Discounting of Costs and Health Effects in Cost-Effectiveness Analysis
|
Westra, Tjalke A.
|
|
2011
|
14 |
8 |
p. 1173-1174
2 p.
|
artikel
|
| 22 |
Practical Implications of Differential Discounting of Costs and Health Effects in Cost-Effectiveness Analysis
|
O'Mahony, James
|
|
2011
|
14 |
8 |
p. 1174-1175
2 p.
|
artikel
|
| 23 |
Preferences for CT Colonography and Colonoscopy as Diagnostic Tests for Colorectal Cancer: A Discrete Choice Experiment
|
Howard, Kirsten
|
|
2011
|
14 |
8 |
p. 1146-1152
7 p.
|
artikel
|
| 24 |
Prioritizing Pharmacogenetic Research: A Value of Information Analysis of CYP2D6 Testing to Guide Breast Cancer Treatment
|
Woods, Beth
|
|
2011
|
14 |
8 |
p. 989-1001
13 p.
|
artikel
|
| 25 |
Response Burden and Questionnaire Length: Is Shorter Better? A Review and Meta-analysis
|
Rolstad, Sindre
|
|
2011
|
14 |
8 |
p. 1101-1108
8 p.
|
artikel
|
| 26 |
Reviewer Acknowledgment
|
|
|
2011
|
14 |
8 |
p. 1176-1180
5 p.
|
artikel
|
| 27 |
Social Valuation of EQ-5D Health States: The Chilean Case
|
Zarate, Victor
|
|
2011
|
14 |
8 |
p. 1135-1141
7 p.
|
artikel
|
| 28 |
Some Cautions on the Use of Instrumental Variables Estimators in Outcomes Research: How Bias in Instrumental Variables Estimators Is Affected by Instrument Strength, Instrument Contamination, and Sample Size
|
Crown, William H.
|
|
2011
|
14 |
8 |
p. 1078-1084
7 p.
|
artikel
|
| 29 |
Structural Frameworks and Key Model Parameters in Cost-Effectiveness Analyses for Current and Future Treatments of Chronic Hepatitis C
|
Townsend, Rebecca
|
|
2011
|
14 |
8 |
p. 1068-1077
10 p.
|
artikel
|
| 30 |
Table of Contents
|
|
|
2011
|
14 |
8 |
p. i-iii
nvt p.
|
artikel
|
| 31 |
The National Institute for Health and Clinical Excellence Single Technology Appraisal Process: Lessons from the First 4 Years
|
Kaltenthaler, Eva
|
|
2011
|
14 |
8 |
p. 1158-1165
8 p.
|
artikel
|
| 32 |
Toward Identifying the Causes and Combinations of Causes Increasing the Risks of Nonadherence to Medical Regimens: Combined Results of Two German Self-Report Surveys
|
Wilke, Thomas
|
|
2011
|
14 |
8 |
p. 1092-1100
9 p.
|
artikel
|
| 33 |
When Evaluating Parameter Uncertainty Is Not Enough: The Case of Dasatinib and Nilotinib for Imatinib-Resistant Chronic Myeloid Leukemia
|
Reed, Shelby D.
|
|
2011
|
14 |
8 |
p. 1055-1056
2 p.
|
artikel
|
Tijdschrift beschrijving